MARKET

BCTX

BCTX

Briacell Therapeutics Corp
NASDAQ
3.070
-0.340
-9.97%
After Hours: 3.010 -0.06 -1.95% 17:12 05/23 EDT
OPEN
3.230
PREV CLOSE
3.410
HIGH
3.340
LOW
3.040
VOLUME
10.40M
TURNOVER
--
52 WEEK HIGH
29.40
52 WEEK LOW
2.814
MARKET CAP
17.55M
P/E (TTM)
-0.6133
1D
5D
1M
3M
1Y
5Y
1D
BriaCell Therapeutics Reports Promising Phase 2 Results for Metastatic Breast Cancer Treatment
TipRanks · 11h ago
BriaCell announces presentation of survival, clinical benefit data at ASCO 2025
TipRanks · 12h ago
BriaCell Therapeutics To Highlight Survival And Clinical Benefit Data In Three Clinical Poster Presentations And One Publish-Only Abstract At 2025 ASCO Annual Meeting
Benzinga · 12h ago
BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025
Barchart · 17h ago
BriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results
TipRanks · 3d ago
BriaCell issues letter to shareholders
TipRanks · 3d ago
BRIEF-Briacell Therapeutics Corp - Bria-Imt Receives FDA Fast Track Designation For Phase 3 Study
Reuters · 3d ago
BriaCell CEO Letter to Shareholders
Barchart · 3d ago
More
About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.